X-group (possible homology)

3129 PBZ domain

Open in classification tree →

Ligands and drugs

Member domains

with ligand contacts (≤ 4 Å)

35.0% of members

with DrugDomain annotations

32.5% of members

with a DrugBank compound

15.0% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

Proteins with classified ligands

Superclasses bound (of 23)

—

Superclasses per 20 proteins

fewer than 20 proteins: too few to compare at equal depth

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

Superclass	Proteins	Expected	Ratio	Significance
Nucleosides, nucleotides, and analogues	2	0.6	3.67×	not tested
Organoheterocyclic compounds	1	0.3	3.29×	not tested
Organic oxygen compounds	1	0.4	2.55×	not tested
Homogeneous metal compounds	2	1.0	2.07×	not tested

enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBank	PDB ligand	Name	Domains
DB00131	AMP	Adenosine phosphate	2
DB00173	ADE	Adenine	2
DB00640	ADN	Adenosine	2
DB16833	ADP	Adenosine disphosphate	2

Most frequently bound compounds

PDB ligand	Name	Domains in contact
ZNmetal	ZINC ION	14
ADE	ADENINE	2
ADN	ADENOSINE	2
ADP	ADENOSINE-5'-DIPHOSPHATE	2
AMP	ADENOSINE MONOPHOSPHATE	2
RIB	alpha-D-ribofuranose	2